Complementary in vivo studies demonstrate that FBXO2 overexpression attenuates disc degeneration in rodent IVDD models, whereas FBXO2 deletion exacerbates disease progression through LCN2‐mediated ferroptotic pathways. This evidence concerns the gene LCN2 and intervertebral disk degenerative disorder.